1.Expert consensus on the application of artificial intelligence in lung cancer screening, diagnosis, and treatment (2026 edition)
Wenzhao ZHONG ; Haibo WANG ; Yi HU ; Hao ZHANG ; Jigang DAI ; Junqiang FAN ; Guibin QIAO ; Fan YANG ; Jian HU ; Fengwei TAN ; Xuening YANG ; Qiang PU ; Zihao CHEN ; Hongxia TIAN ; Lunxu LIU ; Hecheng LI ; Xiaolong YAN ; Zongyang YU ; Zhenbin QIU ; Yihua SUN ; Jing HU ; Yuhang SHI ; Zhifei GUO ; Peng ZHANG ; Kezhong CHEN ; Shugeng GAO ; Yilong WU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(06):848-856
With the continuous deepening of the concept of precision diagnosis and treatment for lung cancer, how to achieve higher efficiency and accuracy in the screening, diagnosis, and treatment pathways in clinical practice has become an important issue that urgently needs to be overcome. The current clinical difficulty lies in the fact that despite continuous advancements in imaging and molecular diagnostic technologies, there are still limitations in manual efficiency and subjective experience when it comes to massive data analysis and multi-scale feature extraction. Artificial intelligence (AI), especially algorithm systems based on deep learning, is an innovative technology capable of deeply empowering medical big data. This method utilizes algorithms such as convolutional neural networks, combined with radiomics, pathomics, and multi-modal data fusion analysis, demonstrating immense potential in early precise detection and benign-malignant differentiation of pulmonary nodules, digital pathological subtype recognition and non-invasive prediction of driver genes, precise 3D surgical planning and automatic delineation of radiotherapy target volumes, as well as dynamic risk warning during follow-up. This innovative technology provides a brand-new solution for realizing intelligent and individualized lung cancer diagnosis and treatment models. This consensus, based on the latest evidence from evidence-based medicine and combined with the development trends in the AI field and real-world clinical needs, was ultimately formed by gathering the consensus opinions of multidisciplinary experts in radiology, pathology, thoracic surgery, and other fields. The main content covers the application specifications of AI in the three core scenarios of lung cancer screening, diagnosis, and treatment, the technical standards for data collection and algorithm validation, as well as the ethical and regulatory challenges faced at the current stage. It aims to clarify the applicable boundaries of AI as a clinical auxiliary decision support tool, providing scientific guidance and standardized exploration directions for peers currently engaged in or planning to carry out AI-assisted clinical diagnosis, treatment, and translation of lung cancer.
2.Association of baseline cerebral blood flow and cerebral metabolic rate of oxygen with sleep structure disorder after thrombolytic therapy in stroke patients and their value in clinical assessment
Journal of Apoplexy and Nervous Diseases 2026;43(4):332-337
Objective To investigate the association of baseline cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) with sleep structure disorder after thrombolytic therapy in stroke patients, as well as their value in clinical assessment. Methods A total of 145 patients with stroke were enrolled as subjects, and all of them received thrombolytic therapy in our hospital from January 2023 to June 2025. Before thrombolytic therapy, 3.0 T magnetic resonance imaging was used to obtain relative CBF (rCBF) and relative CMRO2 (rCMRO2), and rCBF/rCMRO2 ratio was calculated. At week 1 after thrombolysis, overnight polysomnography (PSG) was conducted to obtain parameters such as total sleep time, sleep efficiency, the proportion of each NREM stage, and REM sleep duration. According to the presence or absence of sleep structure disorder, the subjects were divided into disorder group and non-disorder group. The Pearson correlation method was used for correlation analysis. A multivariate logistic regression analysis was used to identify the influencing factors for sleep structure disorder in subjects after thrombolytic therapy. The receiver operating characteristic (ROC) curve was plotted to analyze the performance of rCBF/rCMRO2 ratio in predicting sleep structure disorder in subjects after thrombolytic therapy. Results Compared with the non-disorder group, the disorder group had significantly higher age, infarct volume, NIHSS score on admission, and proportion of patients with infarction in the thalamus (P<0.05). Compared with the non-disorder group, the disorder group had significantly lower rCBF, rCMRO2, rCBF/rCMRO2 ratio, total sleep time, proportion of NREM 3 sleep, proportion of REM sleep, and sleep efficiency (P<0.05) and significantly higher proportion of NREM 1 sleep and sleep arousal index (P<0.05). The Pearson correlation analysis showed that rCBF, rCMRO2, and rCBF/rCMRO2 ratio were positively correlated with total sleep time, proportion of NREM 3 sleep, proportion of REM sleep, and sleep efficiency (P<0.001) and were negatively correlated with the proportion of NREM 1 sleep and sleep arousal index (P<0.001). The Logistic regression analysis showed that age, infarct volume, infarction location (thalamus), and NIHSS score on admission were risk factors for sleep structure disorder in stroke patients after thrombolytic therapy (P<0.05), while rCBF, rCMRO2, and rCBF/rCMRO2 ratio were protective factors against sleep structure disorder (P<0.05). The ROC curve analysis showed that rCBF/rCMRO2 ratio had an area under the ROC curve of 0.901 (95% CI 0.869-0.938) in predicting sleep structure disorder in stroke patients after thrombolytic therapy, with a sensitivity of 95.50% and a specificity of 82.40%. Conclusion Baseline rCBF, rCMRO2, and rCBF/rCMRO2 ratio are closely associated with sleep structure disorder in stroke patients after thrombolytic therapy, among which rCBF/rCMRO2 ratio has excellent performance in predicting sleep structure disorder and can be used as a sensitive indicator for clinical assessment of high-risk patients.
Stroke
3.Analyses of mental health literacy levels and influencing factors among middle school students in Minhang District, Shanghai
Caixia YANG ; Yihua JIANG ; Chao JIANG ; Guo XUAN
Shanghai Journal of Preventive Medicine 2026;38(4):302-310
ObjectiveTo understand the mental health literacy levels and influencing factors among middle school students in Minhang District, Shanghai, and to provide a basis for formulating mental health promotion strategies
4.HydroMg alleviates doxorubicin-induced chronic cardiotoxicity by attenuating oxidative stress and improving mitochondrial function
Lu ZHANG ; Xiurui MA ; Yawei JIN ; Yuning ZHANG ; Xiong GAO ; Mohan LI ; Ze YUAN ; Yihua LU ; Wenjiang DING ; Zhiguang DING ; Xiaolei SUN ; Chunxiao ZHANG ; Jian AN
Chinese Journal of Clinical Medicine 2026;33(4):582-591
Objective To investigate the protective effect and underlying mechanisms of HydroMg, a novel sustained-release hydrogen donor, in a model of doxorubicin (DOX)-induced chronic cardiotoxicity. Methods H9C2 cells were treated with 1 μmol/L DOX and/or 1 μg/mL HydroMg, and mitochondrial membrane potential, reactive oxygen species (ROS) levels, and apoptosis were measured. In the animal experiment, mice were divided into control, HydroMg, DOX, and DOX+HydroMg groups. The HydroMg group received intraperitoneal injection of HydroMg (100 mg/kg). Chronic cardiotoxicity was established by intraperitoneal injection of DOX (5 mg/kg every week) for four consecutive weeks; In the DOX+HydroMg group, HydroMg (100 mg/kg) was administered intraperitoneally 4–5 h prior to each DOX injection. Cardiac function and remodeling were evaluated by echocardiography and heart weight index (HWI). The long-term survival of mice were analyzed. Subsequently, transcriptome sequencing was performed on myocardial tissues from the DOX group to identify key molecular alterations compared with controls. Results At the cellular level, HydroMg treatment effectively reversed DOX-induced mitochondrial dysfunction and oxidative stress, as evidenced by restored membrane potential, reductions in total ROS and mitochondrial superoxide levels by approximately 30% and 9%, respectively, and a decrease in the apoptosis rate from 34.13% to 18.27%. In the animal model, compared with the DOX group, HydroMg intervention increased left ventricular ejection fraction (LVEF) and fractional shortening (LVFS) by 9.62% and 5.82%, respectively, attenuated the reduction in HWI (4.41 mg/mm vs 3.53 mg/mm), and improved the 4-week survival rate (80% vs 60%). Transcriptomic analysis revealed that the core molecular features of DOX-induced cardiotoxicity, including widespread suppression of oxidative phosphorylation and antioxidant pathways. Conclusions HydroMg protects against DOX-induced chronic cardiotoxicity by alleviating oxidative stress and improving mitochondrial function, and provides a potential therapeutic strategy against DOX-related cardiotoxicity.
5.Effect of Modified Longdan Xiegan Tang on Wound Healing and Inflammatory Factors after Surgery for Perianal Abscess of Heat-toxin Accumulation Syndrome
Qian MA ; Shanhu CHEN ; Yihua SONG ; Yanshang WEI
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(20):47-53
ObjectiveTo observe the effects of modified Longdan Xiegan Tang on wound healing and inflammatory factors after surgery for perianal abscess of heat-toxin accumulation syndrome. MethodsA prospective randomized controlled design was adopted. A total of 110 patients with perianal abscess of heat-toxin accumulation syndrome admitted to Hebei Provincial Hospital of Traditional Chinese Medicine from January 2024 to January 2025 were included and randomly assigned into two groups, each with 55 patients according to the random number table method. The control group received conventional Western medicine treatment + placebo oral administration after surgery, and the observation group received modified Longdan Xiegan Tang oral administration on the basis of conventional Western medicine treatment, with a course of 14 days. Clinical efficacy, Visual Analogue Scale (VAS) score, wound secretion score, TCM symptom score, wound healing rate, wound healing time, wound infection rate, inflammatory factors [interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)], wound healing-related indicators [fibronectin (FN), matrix metalloproteinase-9 (MMP-9), and prealbumin (PA)] and adverse reactions were determined in both groups. ResultsThree cases in the observation group and three cases in the control group dropped out, with 104 cases actually completing the study. The repeated measures analysis of variance showed that both groups showed decreased VAS scores, wound secretion scores, TCM syndrome scores, and levels of IL-6, IL-8, TNF-α, and MMP-9 and increased levels of PA and FN after treatment (P<0.05). During treatment and on day 14 after surgery, the observation group had lower VAS score, wound secretion score, TCM syndrome score, and levels of IL-6, IL-8, TNF-α, and MMP-9 and higher levels of PA and FN than the control group (P<0.01). The observation group showed higher wound healing rate, shorter wound healing time, and lower wound infection than the control group (P<0.01). The comprehensive efficacy of the observation group was better than that of the control group (χ2=5.216, P<0.05). No serious adverse events occurred in patients during the study, and there was no significant difference in the incidence of adverse reactions between the two groups. ConclusionModified Longdan Xiegan Tang can ameliorate wound condition, reduce inflammatory response, and promote wound healing in patients with perianal abscess of heat-toxin accumulation syndrome after surgery, with good safety.
6.Effect of Modified Longdan Xiegan Tang on Wound Healing and Inflammatory Factors after Surgery for Perianal Abscess of Heat-toxin Accumulation Syndrome
Qian MA ; Shanhu CHEN ; Yihua SONG ; Yanshang WEI
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(20):47-53
ObjectiveTo observe the effects of modified Longdan Xiegan Tang on wound healing and inflammatory factors after surgery for perianal abscess of heat-toxin accumulation syndrome. MethodsA prospective randomized controlled design was adopted. A total of 110 patients with perianal abscess of heat-toxin accumulation syndrome admitted to Hebei Provincial Hospital of Traditional Chinese Medicine from January 2024 to January 2025 were included and randomly assigned into two groups, each with 55 patients according to the random number table method. The control group received conventional Western medicine treatment + placebo oral administration after surgery, and the observation group received modified Longdan Xiegan Tang oral administration on the basis of conventional Western medicine treatment, with a course of 14 days. Clinical efficacy, Visual Analogue Scale (VAS) score, wound secretion score, TCM symptom score, wound healing rate, wound healing time, wound infection rate, inflammatory factors [interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α)], wound healing-related indicators [fibronectin (FN), matrix metalloproteinase-9 (MMP-9), and prealbumin (PA)] and adverse reactions were determined in both groups. ResultsThree cases in the observation group and three cases in the control group dropped out, with 104 cases actually completing the study. The repeated measures analysis of variance showed that both groups showed decreased VAS scores, wound secretion scores, TCM syndrome scores, and levels of IL-6, IL-8, TNF-α, and MMP-9 and increased levels of PA and FN after treatment (P<0.05). During treatment and on day 14 after surgery, the observation group had lower VAS score, wound secretion score, TCM syndrome score, and levels of IL-6, IL-8, TNF-α, and MMP-9 and higher levels of PA and FN than the control group (P<0.01). The observation group showed higher wound healing rate, shorter wound healing time, and lower wound infection than the control group (P<0.01). The comprehensive efficacy of the observation group was better than that of the control group (χ2=5.216, P<0.05). No serious adverse events occurred in patients during the study, and there was no significant difference in the incidence of adverse reactions between the two groups. ConclusionModified Longdan Xiegan Tang can ameliorate wound condition, reduce inflammatory response, and promote wound healing in patients with perianal abscess of heat-toxin accumulation syndrome after surgery, with good safety.
7.miR-15b-5p affects PIK3CA/AKT1 pathway through USP9X to alleviate airway inflammation in asthma.
Yuyang ZHOU ; Zhiguang WANG ; Yihua PIAO ; Xue HAN ; Yilan SONG ; Guanghai YAN ; Hongmei PIAO
Chinese Journal of Cellular and Molecular Immunology 2025;41(3):193-203
Objective To investigate whether miR-15b-5p can alleviate airway inflammation in asthma by negatively regulating ubiquitin specific peptidase 9X (USP9X) to down-regulate the expression of phosphatidylinositol 4, 5-diphosphate 3-kinase catalytic subunit α/AKT serine/threonine kinase 1 (PIK3CA/AKT1) pathway. Methods USP9X was predicted to be a direct target of miR-15b-5p by using an online database (miRWalk), and the luciferase reporter gene assay was performed to verify it. Co-immunoprecipitation (CO-IP) was used to verify the direct binding between USP9X and PIK3CA and the role of USP9X and its small molecule inhibitor WP1130 in the deubiquitination of PIK3CA. C57 mice were randomly divided into Control group, OVA group, OVA combined with NC group and miR-15b-5p agomir group, with 10 mice in each group. BEAS-2B cells were induced with interleukin 13 (IL-13) and treated with miR-15b-5p mimic. HE, Masson, PAS, immunohistochemistry, immunofluorescence staining, flow cytometry, Western blot and quantitative real-time PCR(qRT-PCR) were performed. Results It was found that the administration of miR-15b-5p agomir and mimic could reduce peribronchial inflammatory cells and improve airway inflammation, and miR-15b-5p could target negative regulation of USP9X. USP9X could directly bind to PIK3CA and regulate PIK3CA level in a proteasome-dependent manner, and USP9X could deubiquitinate K29-linked PIK3CA protein. Down-regulation of USP9X could increase PIK3CA ubiquitination level. WP1130, a small molecule inhibitor of USP9X, has the same effect as knockdown of USP9X, both of which could increase the ubiquitination level of PIK3CA and reduce the protein level of PIK3CA. Conclusion The miR-15b-5p/USP9X/PIK3CA/AKT1 signaling pathway may provide potential therapeutic targets for asthma.
Animals
;
MicroRNAs/metabolism*
;
Asthma/pathology*
;
Class I Phosphatidylinositol 3-Kinases/genetics*
;
Ubiquitin Thiolesterase/metabolism*
;
Proto-Oncogene Proteins c-akt/genetics*
;
Mice
;
Signal Transduction
;
Mice, Inbred C57BL
;
Humans
;
Inflammation/genetics*
;
Cell Line
;
Female
;
Male
8.Outcomes of endoscopic balloon dilation laryngoplasty for acquired subglottic stenosis in children.
Qi LI ; Pengcheng WANG ; Yihua NI ; Letian TAN ; Zhengmin XU ; Chao CHEN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(2):124-127
Objective:To investigate the outcomes of endoscopic balloon dilation laryngoplasty (EBDL) in managing acquired subglottic stenosis in children. Methods:A retrospective analysis of clinical data from patients who underwent endoscopic balloon dilation for secondary subglottic stenosis between January 2017 and January 2024 at Department of Otorhinolaryngology Head and Neck Surgery, Children's Hospital of Fudan University, Shanghai. The study included 10 children (6 males, 4 females) aged between 13 days and 3 years at the time of their first procedure, with an average age of 7 months. Subglottic stenosis was graded according to the Myer-Cotton classification, with two cases classified as grade Ⅱ and eight cases as grade Ⅲ. All patients had a history of tracheal intubation, including seven for rescue purposes and three for operations. Eight cases were complicated by other conditions: two with atrial septal defect, patent ductus arteriosus, and patent foramen ovale; two with patent foramen ovale only; one with atrial septal defect and extreme deafness in the left ear; one with a brain tumor and hydrocephalus; one with a traumatic diaphragmatic hernia and hepatic rupture; and one case complicated by type Ⅰ laryngeal cleft. Prior to surgery, all children required respiratory support-seven needed high-flow oxygen while three required CPAP. Results:All ten cases underwent endoscopic balloon dilation under spontaneous respiration and general anesthesia, totaling fourteen dilations (an average of 1.4 dilations per person) without any complications. Post-surgery air permeability tests showed that eight cases had grade Ⅰ stenosis while two had grade Ⅱ stenosis. The follow-up period ranged from six months to six years (average duration: 46 months). Following treatment, all patients no longer required respiratory support or experienced significant mobility limitations. Conclusion:Endoscopic balloon dilation under general anesthesia is deemed safe and effective in treating secondary subglottic stenosis. Early diagnosis coupled with prompt intervention can help avoid tracheotomy procedures altogether. Standard tracheoscopy combined with breathability testing represents a crucial approach to assess normal airway diameter and effectively reduce or prevent secondary subglottic stenosis following re-intubation.
Humans
;
Laryngostenosis/surgery*
;
Male
;
Female
;
Retrospective Studies
;
Laryngoplasty/methods*
;
Child, Preschool
;
Infant
;
Dilatation/methods*
;
Laryngoscopy/methods*
;
Treatment Outcome
;
Endoscopy
9.A novel anti-ischemic stroke candidate drug AAPB with dual effects of neuroprotection and cerebral blood flow improvement.
Jianbing WU ; Duorui JI ; Weijie JIAO ; Jian JIA ; Jiayi ZHU ; Taijun HANG ; Xijing CHEN ; Yang DING ; Yuwen XU ; Xinglong CHANG ; Liang LI ; Qiu LIU ; Yumei CAO ; Yan ZHONG ; Xia SUN ; Qingming GUO ; Tuanjie WANG ; Zhenzhong WANG ; Ya LING ; Wei XIAO ; Zhangjian HUANG ; Yihua ZHANG
Acta Pharmaceutica Sinica B 2025;15(2):1070-1083
Ischemic stroke (IS) is a globally life-threatening disease. Presently, few therapeutic medicines are available for treating IS, and rt-PA is the only drug approved by the US Food and Drug Administration (FDA) in the US. In fact, many agents showing excellent neuroprotection but no blood flow-improving activity in animals have not achieved ideal clinical efficacy, while thrombolytic drugs only improving blood flow without neuroprotection have limited their wider application. To address these challenges and meet the huge unmet clinical need, we have designed and identified a novel compound AAPB with dual effects of neuroprotection and cerebral blood flow improvement. AAPB significantly reduced cerebral infarction and neural function deficit in tMCAO rats, pMCAO rats, and IS rhesus monkeys, as well as displayed exceptional safety profiles and excellent pharmacokinetic properties in rats and dogs. AAPB has now entered phase I of clinical trials fighting IS in China.
10.Thymosin α1 alleviates pulpitis by inhibiting ferroptosis of dental pulp cells.
Jie WU ; Qimei GONG ; Wenxuan LIU ; Aijia CHEN ; Zekai LIAO ; Yihua HUANG ; Wenkai JIANG ; Zhongchun TONG
International Journal of Oral Science 2025;17(1):68-68
Tooth pulpitis is a prevalent oral disorder. Understanding the underlying mechanisms of pulpitis and developing effective treatment strategies hold great significance. Ferroptosis has recently emerged as a new form of cell death, but the role of ferroptosis in pulpitis remains largely unknown. In our study, single-cell RNA sequencing (scRNA-seq) was used to identify cellular heterogeneity between 3 pulpitis tissue and 3 healthy pulp tissue, and explored ferroptosis occurrence in pulpitis tissue and inflamed dental pulp cells (DPCs). In scRNA-seq, 40 231 cells (Pulpitis: 17 814; Healthy pulp: 22 417) were captured, and visualized into 12 distinct cell clusters. Differentially expressed ferroptosis-related genes (DE-FRGs) were almost presented in each cluster in pulpitis vs healthy pulp. ROS and Fe2+ levels significantly rose, and immunohistochemistry showed low expression of GPX4 and high expression of PTGS2 in pulpitis. In LPS-stimulated DPCs, thymosin α1 increased the expression of GPX4 and FTL, and decreased expression of TNF-α, IL-1β, IL-6, and Fe2+ levels. In rat pulpitis models, both prothymosin α (PTMA, precursor of thymosin α1) gelatin sponge placed at the hole of pulp (LPS-P(gs)) and PTMA injection in pulp (LPS-P(i)) significantly reduced infiltration of inflammatory cells and expression of PTGS2, and increased the expression of GPX4. In RNA sequencing, the expression of DE-FRGs were reversed when thymosin α1 were added in LPS-stimulated DPCs. Collectively, single-cell atlas reveals cellular heterogeneity between pulpitis and healthy pulp, and ferroptosis occurrence in pulpitis. Thymosin α1 may reduce ferroptosis in DPCs to alleviate pulpitis and thus potentially has the ability to treat pulpitis.
Ferroptosis/drug effects*
;
Dental Pulp/drug effects*
;
Animals
;
Pulpitis/pathology*
;
Rats
;
Thymalfasin/pharmacology*
;
Humans
;
Male
;
Thymosin/pharmacology*
;
Disease Models, Animal
;
Rats, Sprague-Dawley

Result Analysis
Print
Save
E-mail